-- (Corrects the year-ago revenue to 182.8 million euros in the third paragraph.)
BioNTech (BNTX) reported a Q1 adjusted loss Tuesday of 1.95 euros ($2.28) per diluted share, widening from a loss of 1.79 euros a year earlier.
Analysts polled by FactSet expected a loss of 1.27 euros.
Revenue for the quarter ended March 31 was 118.1 million euros, compared with 182.8 million euros a year earlier.
Analysts surveyed by FactSet expected 164.6 million euros.
For 2026, the company reaffirmed revenue of between 2 billion euros and 2.30 billion euros. Analysts polled by FactSet expect 2.22 billion euros.
BioNTech shares were down nearly 4.4% in Tuesday premarket activity.
Price: $96.56, Change: $-2.79, Percent Change: -2.81%